Rohit Karnik

Rohit Karnik

Auto-generated profile, based on publicly available information

Rohit Karnik

Massachusetts Institute of Technology

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2012 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
PVPedro M. Valencia
Pedro M. Valencia
OFOmid C. Farokhzad
Omid C. Farokhzad
RKRohit Karnik
Rohit Karnik
RLRobert Langer
Robert Langer

3 October 2017 in Nature Communications
Verified
Journal Article
Open access
PDF file
NBNicolas Bertrand
Nicolas Bertrand
PGPhilippe Grenier
Philippe Grenier
Morteza MahmoudiMorteza Mahmoudi
Morteza Mahmoudi
ELEliana Martins Lima
Eliana Martins Lima
EAEric A. Appel
Eric A. Appel
OFOmid C. Farokhzad
Omid C. Farokhzad
In vitro incubation of nanomaterials with plasma offer insights on biological interactions, but cannot fully explain the in vivo fate of nanomaterials. Here, we use a library of polymer nanoparticles to show how physicochemical characteristics influence blood circulation and early distribution. For particles with different diameters, surface hydrophilicity appears to mediate early clearance. Densities above a critical value of approximately 20 poly(ethylene glycol) chains (MW 5 kDa) per 100 nm2 prolong circulation times, irrespective of size. In knockout mice, clearance mechanisms are identified for nanoparticles with low and high steric protection. Studies in animals deficient in the C3 protein showed that complement activation could not explain differences in the clearance of nanoparticles. In nanoparticles with low poly(ethylene glycol) coverage, adsorption of apolipoproteins can prolong circulation times. In parallel, the low-density-lipoprotein receptor plays a predominant role in the clearance of nanoparticles, irrespective of poly(ethylene glycol) density. These results further our understanding of nanopharmacology.

18 February 2010 in ACS Nano
Verified
Journal Article
Closed access
PVPedro M. Valencia
Pedro M. Valencia
PBPamela A. Basto
Pamela A. Basto
LZLiangfang Zhang
Liangfang Zhang
MRMinsoung Rhee
Minsoung Rhee
RLRobert Langer
Robert Langer
RKRohit Karnik
Rohit Karnik

13 May 2014 in ACS Nano
Verified
Journal Article
Open access
JLJong-Min Lim
Jong-Min Lim
ASArchana Swami
Archana Swami
LGLaura M. Gilson
Laura M. Gilson
SCSunandini Chopra
Sunandini Chopra
SCSungyoung Choi
Sungyoung Choi
OFOmid C. Farokhzad
Omid C. Farokhzad
High-throughput production of nanoparticles (NPs) with controlled quality is critical for their clinical translation into effective nanomedicines for diagnostics and therapeutics. Here we report a simple and versatile coaxial turbulent jet mixer that can synthesize a variety of NPs at high throughput up to 3 kg/d, while maintaining the advantages of homogeneity, reproducibility, and tunability that are normally accessible only in specialized microscale mixing devices. The device fabrication does not require specialized machining and is easy to operate. As one example, we show reproducible, high-throughput formulation of siRNA-polyelectrolyte polyplex NPs that exhibit effective gene knockdown but exhibit significant dependence on batch size when formulated using conventional methods. The coaxial turbulent jet mixer can accelerate the development of nanomedicines by providing a robust and versatile platform for preparation of NPs at throughputs suitable for in vivo studies, clinical trials, and industrial-scale production.

12 November 2012 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
WZWeian Zhao
Weian Zhao
CCCheryl H. Cui
Cheryl H. Cui
SBSuman Bose
Suman Bose
DGDagang Guo
Dagang Guo
CSChong Shen
Chong Shen
JKJeffrey M. Karp
Jeffrey M. Karp
Capture and isolation of flowing cells and particulates from body fluids has enormous implications in diagnosis, monitoring, and drug testing, yet monovalent adhesion molecules used for this purpose result in inefficient cell capture and difficulty in retrieving the captured cells. Inspired by marine creatures that present long tentacles containing multiple adhesive domains to effectively capture flowing food particulates, we developed a platform approach to capture and isolate cells using a 3D DNA network comprising repeating adhesive aptamer domains that extend over tens of micrometers into the solution. The DNA network was synthesized from a microfluidic surface by rolling circle amplification where critical parameters, including DNA graft density, length, and sequence, could readily be tailored. Using an aptamer that binds to protein tyrosine kinase-7 (PTK7) that is overexpressed on many human cancer cells, we demonstrate that the 3D DNA network significantly enhances the capture efficiency of lymphoblast CCRF-CEM cells over monovalent aptamers and antibodies, yet maintains a high purity of the captured cells. When incorporated in a herringbone microfluidic device, the 3D DNA network not only possessed significantly higher capture efficiency than monovalent aptamers and antibodies, but also outperformed previously reported cell-capture microfluidic devices at high flow rates. This work suggests that 3D DNA networks may have broad implications for detection and isolation of cells and other bioparticles.

5 September 2012 in Nature Nanotechnology
Verified
Journal Article
Closed access
PDF file
EWEvelyn N. Wang
Evelyn N. Wang
RKRohit Karnik
Rohit Karnik